Clinical Trials Logo

Clinical Trial Summary

Primary objective To determine BRCA1 and BRCA2 variants in 250 Romanian women with breast/ovarian cancer selected for likeliness to harbor germline mutations in these genes by specific criteria for high-risk status including age at disease onset.

Secondary objective Considering the fact that BRCA testing is not a routine procedure in Romania and mutation prevalence varies in different populations, we intend to look for the founder mutation in our population, running full BRCA genes sequencing to a representative population sample. This would allow a more targeted approach to real-life practice and would ensure personalized solutions for every patient in need.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • To Determine the Prevalence, Penetrance of BRCA1 and BRCA2 Mutations in Romanian Womens With Breast or Ovarian Cancer

NCT number NCT02317120
Study type Observational
Source Prof. Dr. I. Chiricuta Institute of Oncology
Contact
Status Completed
Phase N/A
Start date February 2015
Completion date December 2016